The physiology, signaling, and pharmacology of dopamine receptors

Cites (403)

Items 201–400 of 403

1. Regulation of Dopamine D1 Receptor Function by Physical Interaction with the NMDA Receptors
   Lin Pei, Frank J.S. Lee, Anna Moszczyńska, Brian Vukusic, Fang Liu · 2004 · Journal of Neuroscience
2. G Protein-coupled Receptors Form Stable Complexes with Inwardly Rectifying Potassium Channels and Adenylyl Cyclase
   Natalie E. Lavine, Nathalie Éthier, James N. Oak, Lin Pei, Fang Liu, Phan Trieu, R. Victor Rebois, Michel Bouvier, Terence E. Hébert, Hubert H.M. Van Tol · 2002 · Journal of Biological Chemistry
3. Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1
   Irène Yujnovsky, Jun Hirayama, Masao Doi, Emiliana Borrelli, Paolo Sassone‐Corsi · 2006 · Proceedings of the National Academy of Sciences
4. Neuronal cell death in Huntington’s disease: a potential role for dopamine
   Rebekah J. Jakel, William F. Maragos · 2000 · Trends in Neurosciences
5. A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression
   Benedetti, Francesco, Serretti, Alessandro, Colombo, Cristina, Lorenzi, Cristina, Tubazio, Viviana, Smeraldi, Enrico · 2004 · Neuroscience Letters
6. The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain
   Jeffrey L. Arriza, TM Dawson, Richard B. Simerly, LJ Martin, Marc G. Caron, Solomon H. Snyder, Robert J. Lefkowitz · 1992 · Journal of Neuroscience
7. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans
   Hao Yang Tan, Kristin K. Nicodemus, Qiang Chen, Zhen Li, Jennifer K. Brooke, Robyn A. Honea, Bhaskar S. Kolachana, Richard E. Straub, Andreas Meyer‐Lindenberg, Yoshitasu Sei et al. · 2008 · Journal of Clinical Investigation
8. Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
   Raul R. Gainetdinov, Laura Bohn, Julia K. L. Walker, Stéphane A. Laporte, Alexander D. Macrae, Marc G. Caron, Robert J. Lefkowitz, Richard T. Premont · 1999 · Neuron
9. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
   Xiaohua Li, Kelley Rosborough, Ari B. Friedman, Wawa Zhu, Kevin Aaron Roth · 2006 · The International Journal of Neuropsychopharmacology
10. Seven-Transmembrane Receptor Signaling Through β-Arrestin
    Sudha K. Shenoy, Robert J. Lefkowitz · 2005 · Science s STKE
11. The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons
    Melissa L. Perreault, Ahmed Hasbi, Mohammed Alijaniaram, Theresa Fan, George Kuttiparichel Varghese, Paul J. Fletcher, Philip M. Seeman, Brian F. O’Dowd, Susan R. George · 2010 · Journal of Biological Chemistry
12. Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
    Heidar Alimohamad, Nagalingam Rajakumar, Yam-Hong Seah, Walter J. Rushlow · 2005 · Biological Psychiatry
13. FMRP Acts as a Key Messenger for Dopamine Modulation in the Forebrain
    Wang, Hansen, Wu, Long-Jun, Kim, Susan S., Lee, Frank J.S., Gong, Bo, Toyoda, Hiroki, Ren, Ming, Shang, Yu-Ze, Xu, Hui, Liu, Fang et al. · 2008 · Neuron
14. l ‐DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice
    Emanuela Santini, Cristina Alcacer, Silvia Cacciatore, Myriam Heiman, Denis Hervé, Paul Greengard, Jean‐Antoine Girault, Emmanuel Valjent, Gilberto Fisone · 2008 · Journal of Neurochemistry
15. Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect
    Michael S. Levine, Carlos Cepeda, Miriam Ann Hickey, Sheila M. Fleming, Marie‐Françoise Chesselet · 2004 · Trends in Neurosciences
16. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine
    Maria Lindskog, Per Svenningsson, Laura Pozzi, Yong Deok Kim, Allen A. Fienberg, James A. Bibb, Bertil B. Fredholm, Angus Clark Nairn, Paul Greengard, Gilberto Fisone · 2002 · Nature
17. Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
    Jonathan W. Mink · 2006 · PubMed
18. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
    Caline S. Karam, Jacob S. Ballon, Nancy M. Bivens, Zachary Freyberg, Ragy R. Girgis, José E. Lizardi-Ortiz, Sander Markx, Jeffrey Alan Lieberman, Jonathan A. Javitch · 2010 · Trends in Pharmacological Sciences
19. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White, Francis J., Bednarz, Lisa M., Wachtel, Stephen R., Hjorth, Stephan, Brooderson, Richard J. · 1988 · Pharmacology Biochemistry and Behavior
20. Polymorphisms in dopamine receptors: what do they tell us?
    Albert H.C. Wong, Chris Eric Buckle, Hubert H.M. Van Tol · 2000 · European Journal of Pharmacology
21. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
    Christian C. Felder, Pedro A. José, Joshua L. Axelrod · 1989 · Journal of Pharmacology and Experimental Therapeutics
22. Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
    Mario Tiberi, S. Russel Nash, Lucie Bertrand, Robert J. Lefkowitz, Marc G. Caron · 1996 · Journal of Biological Chemistry
23. Role of the ERK pathway in psychostimulant-induced locomotor sensitization
    Emmanuel Valjent, Jean‐Christophe Corvol, James M. Trzăskos, Jean‐Antoine Girault, Denis Hervé · 2006 · BMC Neuroscience
24. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II
    Jean‐Antoine Girault, H C Hemmings, Kenneth R. Williams, Angus Clark Nairn, Paul Greengard · 1989 · Journal of Biological Chemistry
25. Relative Opioid Efficacy Is Determined by the Complements of the G Protein-Coupled Receptor Desensitization Machinery
    Laura Bohn, L A Dykstra, Robert J. Lefkowitz, Marc G. Caron, Larry S. Barak · 2004 · Molecular Pharmacology
26. D 2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways
    Abraham Kovoor, P Seyffarth, Jana Ebert, Sami Barghshoon, Ching-Kang Chen, Sigrid C. Schwarz, Jeffrey D. Axelrod, Benjamin N. R. Cheyette, Melvin I. Simon, Henry A. Lester et al. · 2005 · Journal of Neuroscience
27. Evidence for Decreased DARPP-32 in the Prefrontal Cortex of Patients With Schizophrenia
    Katherine A. Albert, Hugh C. Hemmings, Anna I. B. Adamo, Steven G. Potkin, Schahram Akbarian, Curt A. Sandman, Carl W. Cotman, William E. Bunney, Paul Greengard · 2002 · Archives of General Psychiatry
28. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D3 receptors
    Joshua D. Joseph, Y.-M Wang, Petrise Runnels Miles, Evgeny A. Budygin, Roberto Picetti, Raul R. Gainetdinov, Marc G. Caron, Robert Mark Wightman · 2002 · Neuroscience
29. Dopamine receptor-interacting proteins: the Ca2+ connection in dopamine signaling
    Clare M. Bergson, Robert G. Levenson, Patricia S. Goldman‐Rakic, Michael S. Lidow · 2003 · Trends in Pharmacological Sciences
30. Autoreceptor Regulation of Dopamine Synthesis
    Marina E. Wolf, Robert Howard Roth · 1990 · Annals of the New York Academy of Sciences
31. Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines
    Woolfrey, Kevin M, Srivastava, Deepak P, Photowala, Huzefa, Yamashita, Megumi, Barbolina, Maria V, Cahill, Michael E, Xie, Zhong, Jones, Kelly A, Quilliam, Lawrence A, Prakriya, Murali et al. · 2009 · Nature Neuroscience
32. Treatment of Acute Severe Hypertension
    Joseph Varón · 2008 · Drugs
33. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test
    James J. Crowley, Julie A. Blendy, Irwin Lucki · 2005 · Psychopharmacology
34. Validating GSK3 as an in vivo target of lithium action
    W. Timothy O'Brien, Peter S. Klein · 2009 · Biochemical Society Transactions
35. Protein Kinase C Mediates Phosphorylation, Desensitization, and Trafficking of the D2 Dopamine Receptor
    Yoon Namkung, David R. Sibley · 2004 · Journal of Biological Chemistry
36. AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families
    Dawn L. Thiselton, Vladimir I. Vladimirov, Po‐Hsiu Kuo, Joseph L. McClay, Brandon Wormley, Ayman H. Fanous, F. Anthony O’Neill, Dermot Walsh, Edwin J. C. G. van den Oord, Kenneth S. Kendler et al. · 2007 · Biological Psychiatry
37. The 'atypicality' of antipsychotics: a concept re-examined and re-defined
    Gerhard Gründer, Hanns Hippius, Arvid Carlsson · 2009 · Nature Reviews Drug Discovery
38. In vivo imaging of synaptic function in the central nervous system
    Susanne Nikolaus, Christina Antke, Hans‐Wilhelm Müller · 2009 · Behavioural Brain Research
39. β-Arrestin/AP-2 Interaction in G Protein-coupled Receptor Internalization
    Stéphane A. Laporte, William E. Miller, Kyeong-Man Kim, Marc G. Caron · 2002 · Journal of Biological Chemistry
40. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons
    Michel Cyr, Jean‐Martin Beaulieu, Aki Laakso, Tatyana D. Sotnikova, Wei‐Dong Yao, Laura Bohn, Raul R. Gainetdinov, Marc G. Caron · 2003 · Proceedings of the National Academy of Sciences
41. D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex
    Tai‐Xiang Xu, Wei‐Dong Yao · 2010 · Proceedings of the National Academy of Sciences
42. Perspectives on the Discovery of Central Monoaminergic Neurotransmission
    Arvid Carlsson · 1987 · Annual Review of Neuroscience
43. Glutamatergic (N-Methyl-d-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?
    Gerard J. Marek, Berthold Behl, Anton Bespalov, Gerhard Groß, Younglim Lee, Hans Schoemaker · 2009 · Molecular Pharmacology
44. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning
    Wen‐Sung Lai, Bin Xu, Koen G.C. Westphal, Marta Paterlini, Berend Olivier, Paul Pavlidis, Maria Karayiorgou, Joseph A. Gogos · 2006 · Proceedings of the National Academy of Sciences
45. Par-4 Links Dopamine Signaling and Depression
    Sang Ki Park, Minh Dang Nguyen, André Fischer, Margaret Po-shan Luke, El Bachir Affar, Paul B. Dieffenbach, Huang-Chun Tseng, Yang Shi, Li‐Huei Tsai · 2005 · Cell
46. DARPP-32, a dopamine- and adenosine 3‘:5‘-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1.
    Hugh C. Hemmings, Angus C. Nairn, Paul Greengard · 1984 · Journal of Biological Chemistry
47. Genotype-Dependent Activity of Tryptophan Hydroxylase-2 Determines the Response to Citalopram in a Mouse Model of Depression
    Luigi Cervo, Alessandro Canetta, Eleonora Calcagno, Silvia Burbassi, G. Sacchetti, Silvio Caccia, Claudia Fracasso, Diego Albani, Gianluigi Forloni, Roberto William Invernizzi · 2005 · Journal of Neuroscience
48. Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease
    Mohamed Rafiuddin Ahmed, Amandine Berthet, Э.Р. Бычков, Grégory Porras, Qin Li, Bernard H. Bioulac, Yonatan T. Carl, Bertrand Bloch, Seunghyi Kook, Incarnation Aubert et al. · 2010 · Science Translational Medicine
49. Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
    Tatyana D. Sotnikova, Jean‐Martin Beaulieu, Larry S. Barak, William C. Wetsel, Marc G. Caron, Raul R. Gainetdinov · 2005 · PLoS Biology
50. Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing
    Bruno Giros A, Marie‐Pascale Martres, Catherine Pilon, Pierre Sokoloff, Jean-Charles Schwartz · 1991 · Biochemical and Biophysical Research Communications
51. Dopaminergic signaling in dendritic spines
    Wei‐Dong Yao, Roger D. Spealman, Jingping Zhang · 2008 · Biochemical Pharmacology
52. Opposite regulation by typical and atypical anti‐psychotics of ERK1/2, CREB and Elk‐1 phosphorylation in mouse dorsal striatum
    Laura Pozzi, Kerstin Håkansson, Alessandro Usiello, Anders Borgkvist, Maria Lindskog, Paul Greengard, Gilberto Fisone · 2003 · Journal of Neurochemistry
53. The dopamine D4 receptor: biochemical and signalling properties
    Pieter Rondou, Guy Haegeman, Kathleen Van Craenenbroeck · 2010 · Cellular and Molecular Life Sciences
54. Exercise activates the phosphatidylinositol 3-kinase pathway
    Michael Jenwei Chen, Amelia A. Russo‐Neustadt · 2005 · Molecular Brain Research
55. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum
    Karima Chergui, Per Svenningsson, Paul Greengard · 2004 · Proceedings of the National Academy of Sciences
56. Pramipexole in Psychiatry
    Chris Aiken · 2007 · The Journal of Clinical Psychiatry
57. Glycogen Synthase Kinase 3 Regulates N-Methyl-d-aspartate Receptor Channel Trafficking and Function in Cortical Neurons
    Paul Chen, Zhenglin Gu, Wenhua Liu, Zhen Yan · 2007 · Molecular Pharmacology
58. Comparative Studies of Molecular Mechanisms of Dopamine D2 and D3 Receptors for the Activation of Extracellular Signal-regulated Kinase
    SunRyeo Beom, Da-Woon Cheong, Gonzalo E. Torres, Marc G. Caron, Kyeong‐Man Kim · 2004 · Journal of Biological Chemistry
59. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
    Susanne Nikolaus, Christina Antke, Hans‐Wilhelm Müller · 2009 · Behavioural Brain Research
60. RGS9–2 Negatively Modulates l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease
    Stephen J. Gold, Chau V. Hoang, Bryan W. Potts, Grégory Porras, Elsa Y. Pioli, Ki Woo Kim, Agnès Nadjar, Chuan Qin, Gerald J. LaHoste, Qin Li et al. · 2007 · Journal of Neuroscience
61. D1-like Dopaminergic Activation of Phosphoinositide Hydrolysis Is Independent of D1A Dopamine Receptors: Evidence from D1A Knockout Mice
    Eitan Friedman, Liqing Jin, Guoping Cai · 1997 · Molecular Pharmacology
62. Plasticity-Associated GeneKrox24/Zif268Is Required for Long-Lasting Behavioral Effects of Cocaine
    Emmanuel Valjent, Benjamin Aubier, Anne-Gaëlle Corbillé, Karen Brami‐Cherrier, Jocelyne Caboche, Piotr Topilko, Jean‐Antoine Girault, Denis Hervé · 2006 · Journal of Neuroscience
63. D1 Receptors Physically Interact with N-Type Calcium Channels to Regulate Channel Distribution and Dendritic Calcium Entry
    Alexandra E. Kisilevsky, Sean J. Mulligan, Christophe Altier, Mircea Iftinca, Diego Varela, Chao Tai, Lina Chen, Shahid Hameed, Jawed Hamid, Brian A. MacVicar et al. · 2008 · Neuron
64. Paradoxical Striatal Cellular Signaling Responses to Psychostimulants in Hyperactive Mice
    Jean‐Martin Beaulieu, Tatyana D. Sotnikova, Raul R. Gainetdinov, Marc G. Caron · 2006 · Journal of Biological Chemistry
65. A kinesin signaling complex mediates the ability of GSK-3β to affect mood-associated behaviors
    Jing Du, Yanling Wei, Lidong Liu, Yun Wang, Rushaniya A. Khairova, Rayah Blumenthal, Tyson R. Tragon, Joshua G. Hunsberger, Rodrigo Machado‐Vieira, Wayne Curtis Drevets et al. · 2010 · Proceedings of the National Academy of Sciences
66. Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
    Carol A. Tamminga, A. Carlsson · 2002 · CNS & Neurological Disorders - Drug Targets
67. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology–molecular biology interface
    John L. Waddington, Colm M. P. O’Tuathaigh, Gerard O'Sullivan, Katsunori Tomiyama, Noriaki Koshikawa, David T. Croke · 2005 · Psychopharmacology
68. BindingDB Entry 4696: Localization and function of the D3 dopamine receptor.
    BindingDB · 2011 · PubMed
69. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions
    Jean‐Marc Taymans, Josée E. Leysen, Xavier Langlois · 2003 · Journal of Neurochemistry
70. A Dopamine D1 Receptor-Dependent β-Arrestin Signaling Complex Potentially Regulates Morphine-Induced Psychomotor Activation but not Reward in Mice
    Nikhil M. Urs, Tanya L. Daigle, Marc G. Caron · 2010 · Neuropsychopharmacology
71. Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development
    Eugenia V. Gurevich, Jeffrey Benovic, Vsevolod V. Gurevich · 2002 · Neuroscience
72. Cannabinoid Action Depends on Phosphorylation of Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa at the Protein Kinase A Site in Striatal Projection Neurons
    Mikael Andersson, Alessandro Usiello, Anders Borgkvist, Laura Pozzi, Cecilia A Dominguez, Allen A. Fienberg, Per Svenningsson, Bertil B. Fredholm, Emiliana Borrelli, Paul Greengard et al. · 2005 · Journal of Neuroscience
73. Calcium Signaling by Dopamine D5 Receptor and D5-D2 Receptor Hetero-Oligomers Occurs by a Mechanism Distinct from That for Dopamine D1-D2 Receptor Hetero-Oligomers
    Christopher H. So, Vaneeta Verma, Mohammad Alijaniaram, Regina Cheng, Asim J. Rashid, Brian F. O’Dowd, Susan R. George · 2009 · Molecular Pharmacology
74. D1 Dopamine Receptor Mediates Dopamine-induced Cytotoxicity via the ERK Signal Cascade
    Jun Chen, Milan Rusnak, Robert R. Luedtke, Anita Sidhu · 2004 · Journal of Biological Chemistry
75. Human Dopamine D3 and D2L Receptors Couple to Inward Rectifier Potassium Channels in Mammalian Cell Lines
    Eldo V. Kuzhikandathil, Weifeng Yu, Gerry Stephen Oxford · 1998 · Molecular and Cellular Neuroscience
76. Dynamin and Rab5 regulate GRK2‐dependent internalization of dopamine D2 receptors
    Ken Iwata, Kazumitsu Ito, Atsushi Fukuzaki · 1999 · European Journal of Biochemistry
77. The Dopamine D2Receptor Regulates the Development of Dopaminergic Neurons via Extracellular Signal-Regulated Kinase and Nurr1 Activation
    Sung Yul Kim, Kyou Chan Choi, Min Seok Chang · 2006 · Journal of Neuroscience
78. l-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain
    Erwan Bézard, Christian E. Gross, Qin Li, Vsevolod V. Gurevich, Jeffrey Benovic, Eugenia V. Gurevich · 2004 · Neurobiology of Disease
79. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin.
    Frédéric Desdouits, Julio C. Siciliano, Paul Greengard, Jean‐Antoine Girault · 1995 · Proceedings of the National Academy of Sciences
80. D5 Dopamine Receptors are Required for Dopaminergic Activation of Phospholipase C
    Asha Sahu, Kimberly R. Tyeryar, H.O. Vongtau, David R. Sibley, Ashiwel S. Undieh · 2008 · Molecular Pharmacology
81. Lifetime Regulation of G Protein–Effector Complex: Emerging Importance of RGS Proteins
    Vadim Y. Arshavsky, Edward N. Pugh · 1998 · Neuron
82. RGS9-2 modulates D 2 dopamine receptor-mediated Ca 2+ channel inhibition in rat striatal cholinergic interneurons
    Theresa M. Cabrera-Vera, Salvador Hernandez, Laurie R. Earls, Martina Medkova, Anna K. Sundgren‐Andersson, Dalton James Surmeier, Heidi E. Hamm · 2004 · Proceedings of the National Academy of Sciences
83. Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms
    Ahmed Hasbi, Brian F. O’Dowd, Susan R. George · 2009 · Current Opinion in Pharmacology
84. Histone H3 Phosphorylation is Under the Opposite Tonic Control of Dopamine D2 and Adenosine A2A Receptors in Striatopallidal Neurons
    Jesus Bertran‐Gonzalez, Kerstin Håkansson, Anders Borgkvist, Théano Irinopoulou, Karen Brami‐Cherrier, Alessandro Usiello, Paul Greengard, Denis Hervé, Jean‐Antoine Girault, Emmanuel Valjent et al. · 2009 · Neuropsychopharmacology
85. Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes
    Richard E. Scranton, Anthony H. Cincotta · 2009 · Expert Opinion on Pharmacotherapy
86. Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain
    Martina Erdtmann-Vourliotis, Peter Eduard Mayer, Susanne Ammon, Uta Riechert, Volker Höllt · 2001 · Molecular Brain Research
87. G Protein-coupled Receptor Kinase Regulates Dopamine D3 Receptor Signaling by Modulating the Stability of a Receptor-Filamin-β-Arrestin Complex
    Kyeong-Man Kim, Raul R. Gainetdinov, Stéphane A. Laporte, Marc G. Caron, Larry S. Barak · 2005 · Journal of Biological Chemistry
88. Dopamine receptor genes: new tools for molecular psychiatry.
    Hyman B. Niznik, Hubert H.M. Van Tol · 1992 · PubMed Central
89. From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
    Mark John Millan · 2010 · Pharmacology & Therapeutics
90. Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3
    Tatiana V. Lipina, Oksana Kaidanovich‐Beilin, Satish Patel, Min Wang, Steven J. Clapcote, Fang Liu, James Robert Woodgett, John Roder · 2010 · Synapse
91. Inhibition of the Dopamine D1 Receptor Signaling by PSD-95
    Jingping Zhang, Ángel Viñuela, Mark H. Neely, Penelope J. Hallett, Seth G. N. Grant, Gregory M. Miller, Ole Isacson A, Marc G. Caron, Wei‐Dong Yao · 2007 · Journal of Biological Chemistry
92. Lithium attenuates Drug-induced Hyperactivity in Rats
    CHRISTINA COX, Philip E. Harrison-Read, Hannah Steinberg · 1971 · Nature
93. Activation of Glycogen Synthase Kinase-3β Is Required for Hyperdopamine and D 2 Receptor-Mediated Inhibition of Synaptic NMDA Receptor Function in the Rat Prefrontal Cortex
    Yan-Chun Li, Dong Xi, Joy Roman, Yue-Qiao Huang, Wen‐Jun Gao · 2009 · Journal of Neuroscience
94. Uncoupling the D1-N-Methyl-D-Aspartate (NMDA) Receptor Complex Promotes NMDA-Dependent Long-Term Potentiation and Working Memory
    Qiang Nai, Shupeng Li, Szu‐Han Wang, Jing Liu, Frank J.S. Lee, Paul W. Frankland, Fang Liu · 2009 · Biological Psychiatry
95. The impact of G‐protein‐coupled receptor hetero‐oligomerization on function and pharmacology
    Roberto Maggio, Francesca Novi, Marco Scarselli, Giovanni Umberto Corsini · 2005 · FEBS Journal
96. Roles of Protein Kinase C and Actin-Binding Protein 280 in the Regulation of Intracellular Trafficking of Dopamine D3 Receptor
    Eun-Young Cho, Dong-Im Cho, Jae H. Park · 2007 · Molecular Endocrinology
97. Looking at Lithium: Molecular Moods and Complex Behaviour
    Jean‐Martin Beaulieu, M. G. Caron · 2008 · Molecular Interventions
98. D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin
    R. Benjamin Free, Lisa A. Hazelwood, David M Cabrera, Heather N. Spalding, Yoon Namkung, Michele L. Rankin, David R. Sibley · 2007 · Journal of Biological Chemistry
99. The GRK4 Subfamily of G Protein-coupled Receptor Kinases
    Richard T. Premont, Alexander D. Macrae, Samuel A. J. R. Aparicio, Humphrey E. Kendall, Jeffrey E. Welch, Robert J. Lefkowitz · 1999 · Journal of Biological Chemistry
100. RGS mRNA Expression in Rat Striatum
     Scott A. Burchett, Michael J. Bannon, James G. Granneman · 1999 · Journal of Neurochemistry
101. PSD-95 Uncouples Dopamine–Glutamate Interaction in the D1/PSD-95/NMDA Receptor Complex
     Jingping Zhang, Tai‐Xiang Xu, Penelope J. Hallett, Masahiko Watanabe, Seth G. N. Grant, Ole Isacson A, Wei‐Dong Yao · 2009 · Journal of Neuroscience
102. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis
     Raul R. Gainetdinov, Tatyana D. Sotnikova, Tatyana V. Grekhova · 1996 · European Journal of Pharmacology
103. The D1 Dopamine Receptor Is Constitutively Phosphorylated by G Protein-Coupled Receptor Kinase 4
     Michele L. Rankin, Paul S. Marinec, David M Cabrera · 2005 · Molecular Pharmacology
104. Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine
     Marc Welter, Daniela Vallone, Tarek A. Samad, Hamid Méziane, Alessandro Usiello, Emiliana Borrelli · 2007 · Proceedings of the National Academy of Sciences
105. Differential Sensitivity of the Short and Long Human Dopamine D2Receptor Subtypes to Protein Kinase C
     Ya Fang Liu, Olivier Civelli, David K. Grandy · 1992 · Journal of Neurochemistry
106. Association between AKT1 gene and Parkinson's disease: A protective haplotype
     Georgia Xiromerisiou, Georgios M. Hadjigeorgiou, Alexandros Papadimitriou, Evaggelos Katsarogiannis, Vasiliki Gourbali, Andrew Singleton · 2008 · Neuroscience Letters
107. Recruitment of β-arrestin2 to the dopamine D2 receptor: Insights into anti-psychotic and anti-parkinsonian drug receptor signaling
     Ib Vestergaard Klewe, Søren Møller Nielsen, L TARPO, Elizabeth Tito Urizar, Concetta Dipace, Jonathan A. Javitch, Ulrik Gether, Jan Egebjerg, Kenneth Vielsted Christensen · 2008 · Neuropharmacology
108. Dopamine D2 receptor stimulation of mitogen‐activated protein kinases mediated by cell type‐dependent transactivation of receptor tyrosine kinases
     Chunhe Wang, David C. Buck, Rui Yang · 2005 · Journal of Neurochemistry
109. Hyperdopaminergic Tone Erodes Prefrontal Long-Term Potential via a D 2 Receptor-Operated Protein Phosphatase Gate
     Tai‐Xiang Xu, Tatyana D. Sotnikova, Chengyu Liang, Jingping Zhang, Jae Ung Jung, Roger D. Spealman, Raul R. Gainetdinov, Wei‐Dong Yao · 2009 · Journal of Neuroscience
110. Development of drugs for gastrointestinal motor disorders: translating science to clinical need
     Gareth John Sanger, David Alpers · 2008 · Neurogastroenterology & Motility
111. G Protein-coupled Receptor Kinase-2 Constitutively Regulates D2 Dopamine Receptor Expression and Signaling Independently of Receptor Phosphorylation
     Yoon Namkung, Concetta Dipace, Eneko Urizar · 2009 · Journal of Biological Chemistry
112. The genetics of attention-deficit/hyperactivity disorder
     David Coghill, Tobias Banaschewski · 2009 · Expert Review of Neurotherapeutics
113. Drug Insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women
     Annamaria Anita Livia Colao, Antonella Di Sarno, Ermelinda Guerra, Monica De Leo, Alberto Mentone, Gaetano Lombardi · 2006 · Nature Clinical Practice Endocrinology &#38 Metabolism
114. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis
     Kjell Fuxé, Daniel J. Marcellino, Giuseppina Leo, Luigi F. Agnati · 2009 · Current Opinion in Pharmacology
115. Dopamine D2–D3 receptor heteromers: pharmacological properties and therapeutic significance
     Roberto Maggio, Mark John Millan · 2009 · Current Opinion in Pharmacology
116. Impaired light masking in dopamine D2 receptor–null mice
     Masao Doi, Irène Yujnovsky, Jun Hirayama, Monica Malerba, Emanuele Tirotta, Paolo Sassone‐Corsi, Emiliana Borrelli · 2006 · Nature Neuroscience
117. Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs
     Jean‐Martin Beaulieu · 2006 · The International Journal of Neuropsychopharmacology
118. D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens
     Agustin Zapata, Toni Shaun Shippenberg · 2002 · Journal of Neurochemistry
119. D2 dopamine receptors interact directly with N-type calcium channels and regulate channel surface expression levels
     Alexandra E. Kisilevsky, Gerald Werner Zamponi · 2008 · Channels
120. Dopamine receptor‐mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time
     Jean‐Marc Taymans, Hossein Kami Kia, Robby Claes, Catarina Cruz, Josée E. Leysen, Xavier Langlois · 2004 · European Journal of Neuroscience
121. Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function
     Chiara Fiorentini, Chiara Busi, PierFranco Spano, Cristina Missale · 2009 · Current Opinion in Pharmacology
122. Emerging drugs for schizophrenia
     Ofer Agid, Shitij Kapur, Gary J. Remington · 2008 · Expert Opinion on Emerging Drugs
123. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism
     Maria Vittoria Podda, E. Riccardi, Marcello D’Ascenzo, Giovan Battista Azzena, Claudio Grassi · 2010 · Neuroscience
124. The dopamine D4 receptors and mechanisms of antipsychotic atypicality
     Albert H.C. Wong, Hubert H.M. Van Tol · 2003 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
125. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine‐treated animal model of schizophrenia and in postmortem schizophrenia brain
     Philip M. Seeman, Françoise Ko, Elaine Jack, Rachel Greenstein, Brian Dean · 2007 · Synapse
126. G Protein-coupled Receptor Kinase 4 (GRK4) Regulates the Phosphorylation and Function of the Dopamine D3 Receptor
     Van Anthony M. Villar, John Edward Jones, Inés Armando et al. · 2009 · Journal of Biological Chemistry
127. Altered expression and subcellular distribution of GRK subtypes in the dopamine‐depleted rat basal ganglia is not normalized by l ‐DOPA treatment
     Mohamed Rafiuddin Ahmed, Э.Р. Бычков, Vsevolod V. Gurevich · 2007 · Journal of Neurochemistry
128. The amyloid precursor protein protects PC12 cells against endoplasmic reticulum stress‐induced apoptosis
     Donat Kögel, Robert Schomburg, Tina Schürmann, Claus Reimertz, Hans‐Georg König, Monika Poppe, Anne Eckert, Walter E. Müller, Jochen H.M. Prehn · 2003 · Journal of Neurochemistry
129. An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis
     Diana Pinto Prata, Gerome D. Breen, Sarah Osborne · 2009 · Psychiatric Genetics
130. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin
     Michel Cyr, Tatyana D. Sotnikova, Raul R. Gainetdinov, Marc G. Caron · 2006 · The FASEB Journal
131. Antipsychotic agents in the treatment of bipolar mania
     Mauricio F. Tohen, Eduard Vieta · 2009 · Bipolar Disorders
132. Different corticostriatal integration in spiny projection neurons from direct and indirect pathways
     Edén Flores-Barrera · 2010 · Frontiers in Systems Neuroscience
133. Confocal analysis of cholinergic and dopaminergic inputs onto pyramidal cells in the prefrontal cortex of rodents
     Zhang · 2010 · Frontiers in Neuroanatomy
134. Molecular Characterization of Human and Rat RGS 9L, a Novel Splice Variant Enriched in Dopamine Target Regions, and Chromosomal Localization of the RGS 9 Gene
     James G. Granneman, Ying Zhai, Zhengxian Zhu · 1998 · Molecular Pharmacology
135. More evidence supports the association of PPP3CC with schizophrenia
     Y L Liu, Cathy S.J. Fann, Chih‐Min Liu, Chien-Ching Chang, W C Yang, Wen‐Hung Chung, Sung‐Liang Yu, Tzung‐Jeng Hwang, Ming Hsien Hsieh, Chen‐Chung Liu et al. · 2007 · Molecular Psychiatry
136. Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.
     Jean‐Antoine Girault, Rita Raisman‐Vozari, Yves Agid · 1989 · Proceedings of the National Academy of Sciences
137. A Dopamine D2 Receptor Mutant Capable of G Protein-Mediated Signaling but Deficient in Arrestin Binding
     Hongxiang Lan, Yong Liu, Michal Bell · 2008 · Molecular Pharmacology
138. Extracellular signal‐regulated kinases (ERKs) modulate cocaine‐induced gene expression in the mouse amygdala
     Kasia Radwańska, Jocelyne Caboche, Leszek Kaczmarek · 2005 · European Journal of Neuroscience
139. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder
     Masanori Ishikawa, Katsuyoshi Mizukami, Masahiko Iwakiri · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
140. Cocaine Self-Administration in Mice Is Inversely Related to Phosphorylation at Thr34 (Protein Kinase A Site) and Ser130 (Kinase CK1 Site) of DARPP-32
     Y. Zhang, Per Svenningsson, Roberto Picetti · 2006 · Journal of Neuroscience
141. Haloperidol and Clozapine Differentially Affect the Expression of Arrestins, Receptor Kinases, and Extracellular Signal-Regulated Kinase Activation
     Mohamed Rafiuddin Ahmed, Vsevolod V. Gurevich, Kevin N. Dalby, Jeffrey Benovic, Eugenia V. Gurevich · 2008 · Journal of Pharmacology and Experimental Therapeutics
142. Blood Pressure and Renal Sodium Handling in Relation to Genetic Variation in the DRD1 Promoter and GRK4
     Jan Albert Staessen, Tatiana Kuznetsova, Haifeng Zhang, Marc P Maillard, Murielle Bochud, Sandra Hasenkamp, Judith Westerkamp, Tom Richart, Lutgarde Thijs, Xinli Li et al. · 2008 · Hypertension
143. Improvement of negative symptoms: concepts, definition and assessment
     Nancy C. Andreasen · 1997 · International Clinical Psychopharmacology
144. Association between the Casein Kinase 1 Epsilon Gene Region and Subjective Response to D-Amphetamine
     Jeremy M. Veenstra-VanderWeele, Asfia Qaadir, Abraham A. Palmer, Edwin H. Cook, Harriet de Wit · 2005 · Neuropsychopharmacology
145. Neuroreceptor imaging in psychiatric disorders
     W. Frankle, M. Laruelle · 2002 · Annals of Nuclear Medicine
146. R7BP Complexes With RGS9-2 and RGS7 in the Striatum Differentially Control Motor Learning and Locomotor Responses to Cocaine
     Garret R. Anderson, Yan Cao, Steve Davidson, Hai Truong, Marco Pravetoni, Mark John Thomas, Kevin Wickman, Glenn J. Giesler, Kirill A. Martemyanov · 2009 · Neuropsychopharmacology
147. Molecular Imaging Studies in Parkinson Disease
     Andre Carvalho Felicio, Ming Chi Shih, Clecio de Oliveira Godeiro-Junior, Luís Eduardo Coelho Andrade, Rodrigo A. Bressan, Henrique Ballalai Ferraz · 2009 · The Neurologist
148. Genetic NMDA Receptor Deficiency Disrupts Acute and Chronic Effects of Cocaine but not Amphetamine
     Amy J. Ramsey, Aki Laakso, Michel Cyr, Tatyana D. Sotnikova, Ali Salahpour, Ivan O. Medvedev, Linda Dykstra, Raul R. Gainetdinov, Marc G. Caron · 2008 · Neuropsychopharmacology
149. Alzheimer-type lesions in Huntington's disease
     K. A. Jellinger · 1998 · Journal of Neural Transmission
150. A Working Hypothesis
     Glenn D. Walters · 1990 · Sage eBooks
151. Peripherin‐mediated death of motor neurons rescued by overexpression of neurofilament NF‐H proteins
     Jean‐Martin Beaulieu, Jean‐Pierre Julien · 2003 · Journal of Neurochemistry
152. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate
     M. Parsons, I. Mata, M. Beperet, F. Iribarren-Iriso, B. Arroyo, R. Sainz, M. Arranz, R. Kerwin · 2007 · Psychiatric Genetics
153. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder
     Karen Torres, Bruno Rezende Souza, Débora Marques de Miranda, Rodrigo Nicolato, Fabrício Souza Neves, A.G.A. Barros, Walderez O. Dutra, Kenneth J. Gollob, Humberto Corrêa, Marco Aurélio Romano‐Silva · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
154. Acute amphetamine down‐regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D ₁ and D ₂ dopamine receptors
     Schwendt, Marek, Gold, Stephen J., McGinty, Jacqueline F. · 2006 · Journal of Neurochemistry
155. Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression
     Charles DeBattista, Jessica Hawkins · 2009 · CNS Drugs
156. Randomized trials of dopamine agonists in restless legs syndrome: A systematic review, quality assessment, and meta-analysis
     Elias Zintzaras, Georgios D. Kitsios, Afroditi A. Papathanasiou, Spyridon Konitsiotis, Michael Miligkos, Paraskevi Rodopoulou, George M. Hadjigeorgiou · 2010 · Clinical Therapeutics
157. Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C
     Anees Ahmad Banday, Fatima Rizwan Fazili, Mustafa F. Lokhandwala · 2007 · American Journal of Physiology-Renal Physiology
158. RGS9-2: probing an intracellular modulator of behavior as a drug target
     John R. Traynor, Dimitra Terzi, Barbara J. Caldarone, Venetia Zachariou · 2009 · Trends in Pharmacological Sciences
159. Genetic Research in Schizophrenia: New Tools and Future Perspectives
     Lars Bertram · 2008 · Schizophrenia Bulletin
160. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder
     Flavie Mathieu, Stéphanie Miot, Bruno Étain, Marie‐Anne El Khoury, Fabien Chevalier, Frank Bellivier, Marion Leboyer, Bruno Giros A, Eleni T. Tzavara · 2008 · Behavioral and Brain Functions
161. Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6
     Kirsten M. Raehal, Cullen L. Schmid, Ivan O. Medvedev, Raul R. Gainetdinov, Richard T. Premont, Laura Bohn · 2009 · Drug and Alcohol Dependence
162. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia
     Laura A. Feldcamp, Renan Pedra de Souza, Marco Aurélio Romano‐Silva, James L. Kennedy, Albert H.C. Wong · 2008 · Schizophrenia Research
163. Pharmacological differentation of classical and novel antipsychotics
     Jørn Arnt · 1998 · International Clinical Psychopharmacology
164. Suppression of the P50 Evoked Response and Neuregulin 1-Induced AKT Phosphorylation in First-Episode Schizophrenia
     Kéri, Szabolcs, Beniczky, Sándor, Kelemen, Oguz · 2010 · American Journal of Psychiatry
165. Identification of RanBP 9/10 as Interacting Partners for Protein Kinase C (PKC) γ/δ and the D1 Dopamine Receptor: Regulation of PKC-Mediated Receptor Phosphorylation
     Elizabeth Rex, Michele L. Rankin, Yu Yang · 2010 · Molecular Pharmacology
166. Ethanol Regulation of D1 Dopamine Receptor Signaling is Mediated by Protein Kinase C in an Isozyme-Specific Manner
     Elizabeth Rex, Michele L. Rankin, Marjorie A. Ariano · 2008 · Neuropsychopharmacology
167. Differential desensitization of dopamine D2 receptor isoforms by protein kinase C: The importance of receptor phosphorylation and pseudosubstrate sites
     Stephen J. Morris, Irit Itzhaki Van‐Ham, Mireille Daigle, Liliane Robillard, Naghmeh Sajedi, Paul R. Albert · 2007 · European Journal of Pharmacology
168. An Intracellular Loop 2 Amino Acid Residue Determines Differential Binding of Arrestin to the Dopamine D2 and D3 Receptors
     Hongxiang Lan, Martha M. Teeter, Vsevolod V. Gurevich · 2008 · Molecular Pharmacology
169. Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study
     Tomoko Toyota, Kazuo Yamada, Sevilla D. Detera‐Wadleigh, Takeo Yoshikawa · 2003 · Neuroscience Letters
170. A Crucial Role for cAMP and Protein Kinase A in D1 Dopamine Receptor Regulated Intracellular Calcium Transients
     Rujuan Dai, Mohammad Kutub Ali, Nelson E. Lezcano · 2008 · Neurosignals
171. Possible association of β‐arrestin 2 gene with methamphetamine use disorder, but not schizophrenia
     Masashi Ikeda, Norio Ozaki, Taroh Suzuki, Tsuyoshi Kitajima, Yoshio Yamanouchi, Yoko Kinoshita, Taro Kishi, Yoshimoto Sekine, Masaomi Iyo, Mutsuo Harano et al. · 2006 · Genes Brain & Behavior
172. Analysis of the actions of the novel dopamine receptor‐directed compounds (S)‐OSU6162 and ACR16 at the D2dopamine receptor
     Elodie Kara, Hong Lin, Kjell A. Svensson · 2010 · British Journal of Pharmacology
173. Forty Years of Antipsychotic Drug Research – from Haloperidol to Paliperidone – with Dr. Paul Janssen
     Frans H. L. Awouters, Paul J Lewi · 2011 · Arzneimittelforschung
174. RGS Proteins: G Protein-Coupled Receptors Meet Their Match
     Scott Chasse, Henrik Gunnar Dohlman · 2003 · Assay and Drug Development Technologies
175. Kinases as drug targets in the treatment of bipolar disorder
     Lisa A. Catapano, Husseini K. Manji · 2008 · Drug Discovery Today
176. The coding‐synonymous polymorphism rs1045280 (Ser280Ser) in β‐arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia
     Ying‐Jay Liou, Y.‐C. Wang, Jen Yeu Chen, Meng‐Ling Chen, Tien‐Wen Chen, Y.‐M. Bai, Chun‐Hung Lin, Ding‐Lieh Liao, I‐Ching Lai · 2008 · European Journal of Neurology
177. Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 ‘Knockout’
     Rachel E. Nally, Fergal N McNamara, Jeremiah J. Clifford, A. Kinsella, Orna Tighe, David T. Croke, Allen A. Fienberg, Paul Greengard, John L. Waddington · 2003 · Neuropsychopharmacology
178. Once and Future Signaling: G Protein-Coupled Receptor Kinase Control of Neuronal Sensitivity
     Richard T. Premont · 2005 · NeuroMolecular Medicine
179. Chapter 7 Biology and Functions of the RGS9 Isoforms
     Kirill A. Martemyanov, Vadim Y. Arshavsky · 2009 · Progress in molecular biology and translational science
180. 3.1 Molecular Pharmacology of the Dopamine Receptors
     Michele L. Rankin, Lisa A. Hazelwood, R. Benjamin Free, Yoon Namkung, Elizabeth Rex, Rebecca A. Roof, David R. Sibley · 2009
181. The Relationship Among Neuregulin 1-Stimulated Phosphorylation of AKT, Psychosis Proneness, and Habituation of Arousal in Nonclinical Individuals
     Szabolcs Kéri, Imola Seres, Ogúz Kelemen, G. Benedek · 2009 · Schizophrenia Bulletin
182. Epistatic and Functional Interactions of Catechol-O-Methyltransferase (COMT) and AKT1 on Neuregulin1-ErbB Signaling in Cell Models
     Yoshitatsu Sei, Zhen Li, Jian Song, Renee F. Ren‐Patterson, Elizabeth M. Tunbridge, Yukihiko Iizuka, Masahiro Inoue, Berenice T. Alfonso, Senda Beltaifa, Yoko Nakai et al. · 2010 · PLoS ONE
183. Pharmacological treatment strategies for schizophrenia
     Jean‐Pierre Lindenmayer, Anzalee Khan · 2004 · Expert Review of Neurotherapeutics
184. Wheel running use in dopamine D2L receptor knockout mice
     Héctor Vargas-Pérez, Emiliana Borrelli, José-Luis Dı́az · 2004 · Neuroscience Letters
185. Association of calcineurin A gamma subunit (PPP3CC) and early growth response 3 (EGR3) gene polymorphisms with susceptibility to schizophrenia in a Japanese population
     Kyogoku, Chieko, Yanagi, Masaya, Nishimura, Kunihiro, Sugiyama, Daisuke, Morinobu, Akio, Fukutake, Masaaki, Maeda, Kiyoshi, Shirakawa, Osamu, Kuno, Takayoshi, Kumagai, Shunichi · 2011 · Psychiatry Research
186. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors.
     Patrick J. Rogue, Jean Zwiller, A N Malviya · 1990 · PubMed
187. Dopamine D1 receptor–mediated aggregation of N-terminal fragments of mutant huntingtin and cell death in a neuroblastoma cell line
     Pierre Robinson, Manon Lebel, Michel Cyr · 2008 · Neuroscience
188. Regulation of dynamin 2 and G protein‐coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration
     Joseph A. Schroeder, Mary R. McCafferty, Ellen M. Unterwald · 2009 · Synapse
189. Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder
     Akira Yoshimi, Nagahide Takahashi, Shinichi Saito et al. · 2007 · Schizophrenia Research
190. Molecular Characterization of Dopamine D2 Receptor Isoforms Tagged With Green Fluorescent Protein
     Keyvan Sedaghat, Marie‐France Nantel, Simon Ginsberg, Véronique Lalonde, Mario Tiberi · 2006 · Molecular Biotechnology
191. Molecular cloning of rat G-protein-coupled receptor kinase 6 (GRK6) from brain tissue, and its mRNA expression in different brain regions and peripheral tissues
     Christoph Fehr, Martina Ficková, Christoph Hiemke, Stefan Reuss, Norbert Dahmen · 1997 · Molecular Brain Research
192. Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas
     Marcello Filopanti, Andrea Gerardo Lania, A. Spada · 2009 · Expert Opinion on Drug Metabolism & Toxicology
193. An association study between PPP1R1B gene and schizophrenia in the Chinese population
     Jianxin Hu, Lan Yu, Yongyong Shi · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
194. Role of dopamine agonists in Parkinson’s disease: an update
     Ubaldo Bonuccelli, Nicola Pavese · 2007 · Expert Review of Neurotherapeutics
195. Ethologically Based Resolution of D2-Like Dopamine Receptor Agonist-versus Antagonist-Induced Behavioral Topography in Dopamine- and Adenosine 3′,5′-Monophosphate-Regulated Phosphoprotein of 32 kDa “Knockout” Mutants Congenic on the C57BL/6 Genetic Background
     Rachel E. Nally, Anthony Kinsella, Orna Tighe · 2004 · Journal of Pharmacology and Experimental Therapeutics
196. Chapter 1 RGS Proteins
     Henrik Gunnar Dohlman · 2009 · Progress in molecular biology and translational science
197. Molecular and cellular events of dopamine D1 receptor‐mediated tau phosphorylation in SK‐N‐MC cells
     Manon Lebel, Michel Cyr · 2010 · Synapse
198. Novel roles for arrestins in G protein-coupled receptor biology and drug discovery.
     Audrey Claing, Stéphane A. Laporte · 2005 · PubMed
199. Arrestin Times for Developing Antipsychotics and β-Blockers
     Miles D. Houslay · 2009 · Science Signaling
200. Central nervous system-acting agents and the treatment of erectile and sexual dysfunction
     Culley C. Carson · 2007 · Current Urology Reports